Axa’s Strategy Inc MSTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-40,266
Closed -$16.3M 687
2025
Q2
$16.3M Buy
40,266
+4,689
+13% +$1.71M 0.05% 314
2025
Q1
$10.3M Buy
35,577
+8,841
+33% +$2.81M 0.03% 379
2024
Q4
$7.74M Buy
+26,736
New +$8.05M 0.02% 433
2021
Q1
Sell
-59,000
Closed -$2.29M 1290
2020
Q4
$2.29M Sell
59,000
-255,940
-81% -$5.98M 0.01% 830
2020
Q3
$4.74M Buy
314,940
+1,000
+0.3% +$13.5K 0.02% 639
2020
Q2
$3.71M Buy
313,940
+24,000
+8% +$292K 0.01% 701
2020
Q1
$3.42M Buy
289,940
+248,940
+607% +$3.38M 0.02% 618
2019
Q4
$585K Buy
+41,000
New +$610K ﹤0.01% 974
2019
Q2
Sell
-247,000
Closed -$3.56M 1329
2019
Q1
$3.56M Buy
247,000
+33,000
+15% +$457K 0.01% 732
2018
Q4
$2.73M Buy
+214,000
New +$2.71M 0.01% 759

Other funds holding MSTR

Axa's MSTR Position: Q3 2025 in Review

Axa sold out of Strategy Inc (MSTR) in Q3 2025, closing a stake of 40,266 shares — an estimated $16.3M sold.

Axa first reported a position in MSTR in Q4 2018 and held it in 10 quarters. The position peaked at $16.3M in Q2 2025. 1,084 funds tracked by Wall St. Rank hold MSTR as of Q3 2025.

  • Axa reported no remaining Strategy Inc position as of Q3 2025 after selling out during the quarter.
  • Axa sold 40,266 Strategy Inc shares in Q3 2025, an estimated $16.3M.
  • Axa first reported a position in Strategy Inc in Q4 2018 and held it in 10 quarters.
  • Axa's Strategy Inc position peaked at $16.3M in Q2 2025.
  • 1,084 funds tracked by Wall St. Rank held Strategy Inc as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.